Detailed answers about ALLIANCE DRUG DEVELOPMENT LIMITED, including incorporation, status, business activity, and accounts information.
When was ALLIANCE DRUG DEVELOPMENT LIMITED founded?
ALLIANCE DRUG DEVELOPMENT LIMITED was officially incorporated on 27 October 2010 and is registered under company number 07420683. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ALLIANCE DRUG DEVELOPMENT LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ALLIANCE DRUG DEVELOPMENT LIMITED?
ALLIANCE DRUG DEVELOPMENT LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ALLIANCE DRUG DEVELOPMENT LIMITED do?
ALLIANCE DRUG DEVELOPMENT LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is ALLIANCE DRUG DEVELOPMENT LIMITED's registered address?
The registered office address of ALLIANCE DRUG DEVELOPMENT LIMITED is VENTURE HOUSE 2 ARLINGTON SQUARE, DOWNSHIRE WAY, BRACKNELL, ENGLAND, RG12 1WA. This is the official address filed with Companies House for legal and statutory correspondence.
Is ALLIANCE DRUG DEVELOPMENT LIMITED financially stable?
The most recent accounts for ALLIANCE DRUG DEVELOPMENT LIMITED were made up to 31 October 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 July 2026.